Novartis expresses regret over South Korea kickbacks fine
MLex Summary: Swiss pharma company Novartis says it is committed to improving compliance procedures after its South Korean arm, Novartis Korea, was hit with a $200,000 fine by South Korea's drug...To view the full article, register now.
Already a subscriber? Click here to view full article